Manufacturer Coupons for Ozempic, Wegovy, Mounjaro, and Zepbound

Manufacturer savings cards and self-pay programs are the most underused lever in GLP-1 pricing. Novo Nordisk and Eli Lilly each run two kinds of program: a savings card that brings a covered prescription down to as little as $25 a month for people with commercial insurance, and a cash self-pay price for everyone else, now as low as $149 a month for the Wegovy pill and for Foundayo. The catch: government insurance is excluded from every card, the savings are capped, and several prices are temporary.

This guide covers the current terms for Wegovy (pen and pill), Ozempic, Zepbound (single-dose pen, KwikPen and vial), Mounjaro and Foundayo, plus the Medicare GLP-1 Bridge. Programs change without notice, so confirm the terms on the manufacturer's site before you fill.

Last verified: September 2026, from each manufacturer's own savings and terms pages.

Key Takeaways

• Wegovy Savings Card (pen and pill): as little as $25 a month with commercial insurance that covers Wegovy, with savings capped at $100 a month.
• Wegovy self-pay: the pill is $149 a month at 1.5 mg, $199 at 4 mg and $299 at 9 mg and 25 mg. The pen is $349 a month ($199 for the first two fills at 0.25 or 0.5 mg for new patients through December 31, 2026).
• Ozempic Savings Card: as little as $25 a month with commercial coverage for Ozempic, savings capped at $100 a month, for up to 48 months.
• Zepbound Savings Card: as little as $25 a month for the single-dose pen with commercial coverage, capped at $100 a month and $1,300 a year.
• Zepbound self-pay (KwikPen or vial): $299 a month at 2.5 mg, $399 at 5 mg and $449 at 7.5 mg to 15 mg when you refill within 45 days.
• Mounjaro Savings Card: as little as $25 a month with commercial coverage, capped at $150 a month; $499 a month if your commercial plan does not cover it.
• Foundayo: $25 a month with commercial coverage and the savings card; $149 to $349 a month self-pay through LillyDirect depending on dose.
• Government insurance is excluded from every savings card: Medicare, Medicaid, TRICARE, VA and similar programs. Medicare Part D patients have a separate route: the Medicare GLP-1 Bridge at $50 a month for Wegovy, Foundayo and the Zepbound KwikPen.
• Benefits are capped by the month and by the year, and every Lilly card expires December 31, 2026.

How Manufacturer Savings Cards Work

A savings card (sometimes called a copay card or coupon) is a program the manufacturer pays on your behalf. You present the card with your insurance at the pharmacy, the pharmacy processes it as a secondary payer, and the manufacturer covers the difference down to the card price, up to a cap.

A self-pay program is different. You buy the drug for cash, outside your insurance, at a fixed price set by the manufacturer. Novo Nordisk sells through NovoCare Pharmacy and Lilly through LillyDirect. Anyone with a prescription can use self-pay, but the purchase does not go through your plan, so it does not count toward your deductible.

Every savings card in this guide excludes people enrolled in a government health program. Novo Nordisk's Wegovy terms spell out that the Federal Employees Health Benefits Program, Affordable Care Act exchange plans and state employee plans are not government programs for this purpose, so people on those plans can use the card.

For the full pricing context across all pathways, see the real cost of Wegovy.

Novo Nordisk Wegovy Savings Card

Wegovy's program matters most because Wegovy's list price is $1,349.02 a package for both the pen and the pill, and it now covers both forms.

If your insurance covers Wegovy (pen or pill)

• Monthly cost: as little as $25
• Maximum savings: $100 per 1-month fill, $200 per 2-month fill, $300 per 3-month fill
• What counts as a month: 1 box of 4 pens, or 1 bottle of 30 tablets
• Requires: commercial insurance that covers Wegovy and a prescription for an FDA-approved use

If your insurance does NOT cover Wegovy, or you pay cash

Novo Nordisk's self-pay offer is for people whose insurance does not cover Wegovy or who choose to buy outside their plan.

A pill month is 1 bottle of 30 tablets; a pen month is 1 box of 4 pens. The 4 mg pill was $149 under an introductory offer that ended August 31, 2026. See Wegovy cost, pen and pill for how these compare with sellers.

Who is eligible for the card

• A valid prescription for Wegovy for an FDA-approved use
• Commercial or private insurance, including FEHB, ACA exchange and state employee plans
• Not enrolled in Medicaid, Medicare, VA, DoD, TRICARE or a similar federal or state program
• Valid in the United States and its territories

Who is NOT eligible for the card

• Patients with government insurance (Medicare Part D patients can look at the Medicare GLP-1 Bridge below)
• People without commercial insurance, who use the self-pay prices above instead
• In Massachusetts, availability depends on state law in effect when you fill

Enroll at the official Wegovy savings page.

Novo Nordisk Ozempic Savings Card

Ozempic's approval covers type 2 diabetes only, and the card works only if your plan covers Ozempic.

Terms

• Monthly cost: as little as $25
• Maximum savings: $100 a month
• Duration: up to 48 months
• Requires: commercial insurance that covers Ozempic and a valid prescription

Self-pay

• New patients: $199 a month for each of your first 2 fills, on the 0.25 mg or 0.5 mg dose, through December 31, 2026
• Then: $349 a month on the 0.25, 0.5 or 1 mg dose; $499 a month on the 2 mg dose

Novo Nordisk states that Medicare Part D and Medicaid patients cannot use the $25 offer but can use self-pay, which is bought outside insurance and cannot be claimed back from a plan.

Enroll at the official Ozempic savings page.

Eli Lilly Zepbound Savings Card

Zepbound now comes in three presentations with different price routes: the single-dose pen (autoinjector), the multi-dose KwikPen that holds four weekly doses, and the single-dose vial.

If your insurance covers the Zepbound single-dose pen

• Monthly cost: as little as $25, whether the fill covers 1, 2 or 3 months
• Maximum savings: $100 a month and $1,300 a calendar year
• Fills: up to 13 a calendar year
• Card ends: December 31, 2026

If your commercial insurance does NOT cover Zepbound

• Single-dose pen: as low as $499 a month, up to 13 fills a year
• KwikPen: the card prices it at the self-pay levels below ($299 to $449), up to 11 fills a year

Zepbound self-pay: KwikPen and single-dose vial

Lilly sells the KwikPen and the single-dose vial for cash through LillyDirect at the same prices. A month is 28 days: 1 KwikPen or 4 vials.

The $449 rate is Lilly's Self Pay Journey Program price and holds only when each refill is completed within 45 days of the previous delivery. Pen needles are sold separately for the KwikPen; vials need syringes and needles. The single-dose pen is not sold at these self-pay prices. For KwikPen doses, priming and storage, see the Zepbound KwikPen dose chart.

This is not a coupon; it is a direct purchase program, available with or without insurance, and it is one of the lowest brand-name tirzepatide prices available. See the official Zepbound savings page for current terms.

Eli Lilly Mounjaro Savings Card

Mounjaro's approval is for type 2 diabetes, so the card requires a prescription for an approved use.

Terms

• With coverage for Mounjaro: as little as $25 on a fill of 1, 2 or 3 months, with savings capped at $150 a month and $1,950 a calendar year, up to 13 fills a year
• Commercial insurance without coverage for Mounjaro: as low as $499 a month, with savings capped at $647 a month and $8,411 a year
• Card ends: December 31, 2026

Enroll at the official Mounjaro savings page.

Eli Lilly Foundayo Savings Card and Self-Pay

Foundayo (orforglipron) is Lilly's once-daily GLP-1 pill for weight management.

If your insurance covers Foundayo

• Monthly cost: as little as $25, on a 1, 2 or 3 month fill
• Maximum savings: $100 a month, $1,000 a calendar year
• Fills: up to 10 a calendar year
• Card ends: December 31, 2026

Foundayo self-pay through LillyDirect

A month is 30 days, one tablet a day.

People with commercial insurance that does not cover Foundayo pay the same levels through the card. Savings may not be applied at the pharmacy counter; Lilly's terms allow a reimbursement claim afterward. See Foundayo price by dose for what sellers charge.

Medicare GLP-1 Bridge

Medicare Part D patients cannot use the savings cards in this guide, but a separate program now covers weight-management GLP-1s:

• Cost: $50 a month
• Covered: all doses of the Wegovy pen and pill (Novo Nordisk), and Foundayo and the Zepbound KwikPen for weight management (Lilly). The Zepbound single-dose pen and single-dose vials are not covered.
• Dates: Novo Nordisk describes it as a temporary federal program running July 1, 2026 to December 31, 2027
• Requires: Medicare Part D, a prescription for chronic weight management, prior authorization, and a BMI of 35 or higher (or 27 or higher with certain weight-related conditions). Some plan types are excluded.
• Not eligible: Zepbound prescribed for obstructive sleep apnea

All Programs at a Glance

Common Fine Print You Should Know

1. Lilly's fill limits run by calendar year, and the cards expire

Every Lilly card in this guide counts fills and savings per calendar year and ends December 31, 2026: 13 fills for the Zepbound single-dose pen and Mounjaro, 11 for the Zepbound KwikPen, 10 for Foundayo. Novo Nordisk's Ozempic card runs for up to 48 months.

2. Re-enrollment may be required

When a card expires, the next year's program may have different terms. Don't assume today's card will work next year.

3. State law can limit coupons

Novo Nordisk's Wegovy terms say the card's availability in Massachusetts depends on the state law in effect when you fill. Check the manufacturer page if you live in a state with coupon rules.

4. Pharmacy processing varies

Some savings are not applied at the counter. Lilly's Foundayo terms, for example, provide a reimbursement claim when the pharmacy could not confirm the 45-day refill discount at checkout. Ask before filling, and keep your receipt.

5. Medicare rules out the cards, not every discount

Medicare beneficiaries cannot use any of the savings cards in this guide. They can use the Medicare GLP-1 Bridge for the drugs it covers, and Novo Nordisk says Part D patients can also use its self-pay prices, as long as they do not claim the cost from their plan.

6. Deductibles: cards and cash differ

Novo Nordisk says it intends card savings to count toward your out-of-pocket costs and deductible, but some plans run programs that change how manufacturer assistance is counted, so check with your plan. Cash self-pay purchases are made outside insurance and do not count toward your deductible or out-of-pocket maximum.

Who Should Use Which Program

Use the Wegovy savings card if: you have commercial insurance that covers Wegovy, pen or pill.

Use Wegovy self-pay if: your plan does not cover it or you have no insurance; the pill is the lower-cost form at $149 to $299.

Use the Ozempic savings card if: you have type 2 diabetes and commercial insurance covering Ozempic.

Use the Zepbound savings card if: your commercial plan covers the single-dose pen.

Use Zepbound self-pay (KwikPen or vial) if: you want brand-name tirzepatide for weight loss and your plan does not cover it.

Use the Mounjaro savings card if: you have type 2 diabetes and commercial insurance.

Use the Foundayo savings card or self-pay if: you want a daily pill; self-pay starts at $149.

Use the Medicare GLP-1 Bridge if: you have Medicare Part D and a weight-management prescription for Wegovy, Foundayo or the Zepbound KwikPen.

Don't bother with manufacturer cards if:

• You have Medicaid, TRICARE or VA coverage (you're excluded; ask your plan about its own GLP-1 coverage)
• You're uninsured (use the self-pay prices instead)
• Your monthly cost on compounded semaglutide or tirzepatide is already below the self-pay price

Compounded Alternatives

For patients who don't qualify for savings cards, or who find the brand self-pay prices too high, compounded semaglutide and tirzepatide are usually cheaper. In September 2026, the middle of our seller register was about $188 a month for compounded semaglutide and $250 a month for compounded tirzepatide, with the lowest sellers well below that. Compounded drugs are not FDA-approved finished products.

See our best GLP-1 providers ranking and compounded semaglutide safety guide before choosing this path.

Do's and Don'ts

Do:

• Verify current program terms on the manufacturer site before enrolling
• Bring your card (or app screenshot) to the pharmacy at every fill
• Ask the pharmacist to confirm the discount was applied before paying
• Refill Zepbound or Foundayo within 45 days if you rely on the Journey Program price
• Track your fill count against the yearly limit

Don't:

• Assume savings cards work with any insurance
• Use a savings card while enrolled in Medicare, Medicaid, TRICARE or VA; the terms exclude you
• Skip reading the fine print on monthly and yearly caps
• Rely on outdated coupon numbers from unofficial sites; always go to the manufacturer's page

Bottom Line

With commercial coverage, every brand GLP-1 in this guide can cost as little as $25 a month through the manufacturer's card, within the caps. Without coverage, the cheapest brand-name routes are now the pills and the Lilly self-pay programs: the Wegovy pill and Foundayo from $149 a month, and the Zepbound KwikPen or vial from $299. Medicare Part D patients who qualify pay $50 through the Medicare GLP-1 Bridge.

Before making any pricing decision, run your situation through our savings calculator and compare against compounded options in our best providers ranking. And always confirm the current terms on the manufacturer site before filling your prescription.